Skip to content

The Blended Care Intervention Booster for Youth With Chronic Health Conditions to Increase Fatigue-related Self-efficacy

Blended Therapy for Youth With a Chronic Health Condition to Increase Fatigue-related Self-efficacy (Booster): Protocol for a Multiple Baseline Single Case Experimental Study

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06562335
Enrollment
20
Registered
2024-08-20
Start date
2024-09-15
Completion date
2025-10-01
Last updated
2024-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Illnesses, Fatigue

Keywords

Chronic childhood disease, Fatigue, Self-efficacy, mHealth, Pediatrics, Single case

Brief summary

The goal of this experimental study is to learn if the Booster intervention can be used as an early intervention for persistent fatigue. The aim of the intervention is to prevent more fatigue-related disabilities in young people with chronic illnesses like inflammatory bowel disease, childhood cancer, and juvenile idiopathic arthritis by improving self-confidence in managing fatigue (fatigue-related self-efficacy or FSE). The main questions this study aims to answer are: * What is the effect of the Booster intervention on fatigue-related self-efficacy (FSE)? * What is the effect of the Booster intervention on fatigue levels, school participation, life satisfaction, and perceived health? * When does improvement in study outcomes happen relative to the Booster intervention? * What participant characteristics predict change in study outcomes? Participants will follow the Booster intervention. Booster is a personalised, blended care intervention designed to help young people understand how their thoughts, feelings, and activities impact their fatigue using a smartphone app. The Booster app uses experience sampling methodology (ESM) to track these fluctuations. Based on insights obtained from these data, the participant and their healthcare provider can set personal lifestyle goals, such as increasing physical activity and reducing daytime naps. An earlier version of this intervention, called PROfeel, was effective in reducing severe fatigue. The investigators have now improved the app to also help with setting and achieving personal goals and monitoring daily progress. The investigators will measure the effect of Booster through daily questionnaires during two phases: Phase A (baseline, before the goal setting between patient and healthcare provider) and Phase B (intervention, starting in the lifestyle change period). The duration of Phase A will be randomised for each participant.

Interventions

OTHERBooster

See description of arm. The Booster intervention has evolved from the PROfeel intervention. PROfeel is described in: https://doi.org/10.1186/s13063-022-06620-2

Sponsors

Netherlands Organisation for Scientific Research
CollaboratorOTHER_GOV
UMC Utrecht
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

multiple baseline single case experimental AB-phase design

Eligibility

Sex/Gender
ALL
Age
12 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Experiencing fatigue for at least 3 months and feeling hindered by it (Pediatric Short Fatigue Questionnaire (pSFQ) score of 15 or higher) * Diagnosed with a chronic health condition or treated for childhood cancer

Exclusion criteria

Regarding other treatments: * Fatigue fully explained by a somatic or psychiatric diagnosis * Chronic health condition unstable in the last 3 months (e.g., recent medication changes or cancer relapse) * Significant functional limitations due to fatigue (e.g., more than 50% school absenteeism) Regarding feasibility: * Cognitive impairment with an estimated IQ of below 70 * No smartphone with internet access * Unable to speak, read, understand, or write Dutch

Design outcomes

Primary

MeasureTime frameDescription
Fatigue-related self-efficacyDaily before and during the intervention, for approximately 130 daysSingle-item question, self-report via Booster app. The single item was designed and validated for this study. Answered on a VAS scale 0 to 100. Higher score represents higher fatigue-related self-efficacy.

Secondary

MeasureTime frameDescription
Life satisfactionDaily before and during the intervention, for approximately 130 daysCantril Ladder, single-item question, rate life with ladder numbered from 0 to 10. Top of the ladder (10) represents the best possible life. The bottom (0) represents the worst possible life.
Fatigue severityDaily before and during the intervention, for approximately 130 dayspediatric short fatigue questionnaire, 4-item questionnaire, answered on a seven point Likert scale (1 = yes that is true, 7=no, that is not true). Total score ranges from 4 to 28, with higher scores reflecting more fatigue.
ParticipationDaily before and during the intervention, for approximately 130 daysSchool or work presence. Calculated: (hours present/the hours scheduled)\*100
Perceived healthDaily before and during the intervention, for approximately 130 daysEuroQol (EQ) visual analogue scale (VAS), ranging from 0 (worst health you can imagine) to 100 (best health you can imagine).

Other

MeasureTime frameDescription
MasteryBaseline, 3 months, 6 months, and if interim analysis show medium to large change also at 12 monthsPearlin Schooler Mastery Scale, a seven-item questionnaire, answered on a four-point Likert scale, ranging from strongly disagree (1) to strongly agree (4). Total score ranges from 7 to 28, with higher scores reflecting higher levels of mastery.
Fatigue-related self-efficacyBaseline, 3 months, 6 months, and if interim analysis show medium to large change also at 12 monthsSelf-Efficacy Scale-28 (SES-28) , 7-item questionnaire answered on a four-point likert scale, total scores range from 7 to 28 with higher scores indicating higher sense of control over fatigue.
Physical activityBaseline, 3 months, 6 months, and if interim analysis show medium to large change also at 12 monthsPhysical Activity Questionnaire for Adolescents (PAQ-A), a nine-item questionnaire. The first eight items are answered on a five-point Likert scale, ranging from low (1) to high (5) levels of physical activity. The ninth item asks whether the past week's activity was typical, less than typical, or more than typical, to provide context for the responses.The total score is calculated by averaging the scores of the first 8 items, yielding a final score ranging from 1 to 5. Higher scores indicate higher levels of physical activity.
FatigueBaseline, 3 months, 6 months, and if interim analysis show medium to large change also at 12 monthsPEDsQL-MFS, 23-item questionnaire
Health-related quality of lifeBaseline, 3 months, 6 months, and if interim analysis show medium to large change also at 12 monthsPediatric Quality of Life Inventory-Generic Core Scales (PEDsQL-GCS), a 23-item questionnaire answered on a five-point likert (0=never, 4 = almost always), total score ranging from 0 to 92, with higher scores representing higher quality of life. The questionnaire has the following subscales: physical, emotional, social and school or work functioning.
School or work absenceBaseline, 3 months, 6 months, and if interim analysis show medium to large change also at 12 monthsSingle item question on average absence over past half a year in %
Illness identity - fatigueBaseline, 3 months, 6 months, and if interim analysis show medium to large change also at 12 monthsIllness identity questionnaire (ILQ), a 25-item questionnaire, answered on a five-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). It has the following subscales: engulfment (8 items, range 8 to 40), rejection (5 items, range 5 to 25), acceptance (5 items, range 5 to 25) and enrichment (7 items, range 7 to 35). Higher scores on subscales represent respectively higher engulfment, rejection, acceptance and enrichment. The questionnaire is adapted to specifically ask for illness identity regarding fatigue (e.g., I refuse to see my fatigue as part of myself)

Countries

Netherlands

Contacts

Primary ContactMD Stutvoet, MSC, M.D.
booster@umcutrecht.nl+3188 755 5555
Backup ContactA Vroegindeweij, MSC
+3188 755 5555

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026